Literature DB >> 50336

Acute anaphylaxis associated with serum complement depletion.

H Tannenbaum, S Ruddy, P H Schur.   

Abstract

A 45-year-old woman with rheumatoid arthritis developed anaphylaxis 6 min after receiving a subcutaneous injection of lidocaine, followed by an intra-articular injection of lidocaine mixed with methprednisolone acetate. One hour after the onset of anaphylaxis, serum complement component levels were markedly depressed and remained so far 18 hr. Circulating immune complexes and antibodies to lidocaine could not be demonstrated. Neither lidocaine nor methylprednisolone acetate activated the patient's complement system in vitro. Subsequently, total hemolytic activity (CH50) levels were variable, complement component protein concentrations of C1q, C1s, C4, C2, C3, C5, C6, C9, and Factor B were normal, but hemolytic activity of C4 and C2 was diminished. Serum C1 inhibitor concentrations were normal or slightly depressed. The patient has never had any symptoms suggestive of angiodema. It is postulated that the endogenous complement abnormality present in this patient may have contributed to the anaphylactic reaction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50336     DOI: 10.1016/0091-6749(75)90094-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

Review 1.  Anaphylactic and anaphylactoid reactions due to anesthetic agents.

Authors:  M Schatz; D L Fung
Journal:  Clin Rev Allergy       Date:  1986-05

Review 2.  Anaphylaxis.

Authors:  A I Terr
Journal:  Clin Rev Allergy       Date:  1985-02

3.  The epidemiology of anaesthetic anaphylactoid reactions in Australasia.

Authors:  M M Fisher
Journal:  Klin Wochenschr       Date:  1982-09-01

4.  Complement-dependent hemodynamic and hematologic changes in the rabbit.

Authors:  R J Ulevitch; C G Cochrane
Journal:  Inflammation       Date:  1977-09       Impact factor: 4.092

5.  Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

Authors:  Leonard H Calabrese; Arthur Kavanaugh; Anthony E Yeo; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2017-08-17       Impact factor: 5.156

Review 6.  Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities.

Authors:  Zeinab Mohseni Afshar; Arefeh Babazadeh; Alireza Janbakhsh; Feizollah Mansouri; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Rezvan Hosseinzadeh; Mohammad Barary; Soheil Ebrahimpour
Journal:  Rev Med Virol       Date:  2021-10-22       Impact factor: 11.043

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.